Intra-Mobile Therapies (ITCI): Parkinson’s Illness Drug Enlargement Might Be The Subsequent Transfer
This text was written byComply withTerry Chrisomalis is a non-public investor within the Biotech sector with years of expertise using ...
Sunday, December 15, 2024
Tag: Therapies
Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Name Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2024 Earnings Convention Name August 12, 2024 8:30 AM ET Firm Contributors Hayleigh Collins ...
Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry (CRSP)
Bill Oxford CASGEVY approval CASGEVY is a groundbreaking gene therapy, owned by CRISPR Therapeutics AG (CRSP) and Vertex (VRTX) specifically ...
Lilly, Scribe team up for neuro diseases CRISPR therapies
rommma Scribe Therapeutics is collaborating with Eli Lilly's unit (NYSE:LLY) Prevail Therapeutics and granted rights to its CRISPR X-Editing (XE) ...
Cancer therapies spending set to surge through end of decade
Design Cells/iStock via Getty Images The market for oncology drugs is set to surge between now and the end of ...
Rare success for Alzheimer’s research unlocks hope for future therapies By Reuters
2/2 © Reuters. FILE PHOTO: A test tube is seen in front of displayed Biogen logo in this illustration taken, ...
Taysha Gene Therapies: Astellas Throws Lifeline For On Rett And GAN Programs (NASDAQ:TSHA)
Artur PlawgoShares of Taysha Gene Therapies (NASDAQ:TSHA) have fallen by 85% since the September 2020 IPO was priced at $20. ...
Intra-Cellular Therapies Stock: What Lies Ahead (NASDAQ:ITCI)
Eoneren Happy people produce. Bored people consume.”― Stephen Richards It has been some time since we last looked in on ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.